STOCKHOLM, Sweden, Nov. 27, 2009 (GLOBE NEWSWIRE) -- Diamyd Medical's Annual Report for 2008/2009 from today is available in Swedish on the company website, www.diamyd.com.

A printed Annual Report can be ordered by mail to Diamyd Medical, Linnegatan 89 B, SE-115 23 Stockholm, or by e-mail to investor.relations@diamyd.com.

Diamyd Medical's Annual General Meeting takes place on Friday December 11, 2009 at 3:00 p.m. at the IVA Conference Center, Grev Turegatan 16 (Wallenberg auditorium) in Stockholm.

The English translation of the Annual Report will be available in approximately two weeks.

 For more information, please contact:
 Elisabeth Lindner, President and CEO Diamyd Medical AB (publ.)
 Phone: +46 8 661 0026

 For pictures and press material, please contact:
 Andreas Ericsson, Diamyd Medical AB (publ.)
 andreas.ericsson@diamyd.com
 Phone: +46 8 661 0026

About Diamyd Medical

Diamyd Medical is a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications. The company's most advanced project is the GAD-based drug Diamyd(R) for type 1 diabetes. Phase III trials for this drug are in progress in both Europe and the U.S. In addition, the company has initiated clinical studies in the U.S. in the area of chronic pain, using its Nerve Targeting Drug Delivery System (NTDDS).

The company has also out-licensed the use of GAD for the treatment of Parkinson's disease. The company currently has three clinical-phase products.

Diamyd Medical has offices in Sweden and in the U.S. Shares are listed on Nasdaq OMX in Stockholm (ticker: DIAM B) and on OTCQX in the U.S. (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

Further information is available on the company's website: www.diamyd.com.

This information is disclosed in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements.

 Diamyd Medical AB (publ.)
 Linnegatan 89 B, SE-115 23 Stockholm, Sweden.
 Tel: +46 (0)8 6610026, Fax: +46 (0)8 661 63 68
 E-mail: info@diamyd.com. VAT no: SE556530-142001.